Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: a modular phase I trial in androgen-independent prostate cancer (Q45018087)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: a modular phase I trial in androgen-independent prostate cancer |
scientific article |
Statements
1 reference
Platelet-derived growth factor receptor inhibitor imatinib mesylate and docetaxel: a modular phase I trial in androgen-independent prostate cancer (English)
1 reference
Isaiah J Fidler
1 reference
Christopher Logothetis
1 reference
Paul Mathew
1 reference
Peter F Thall
1 reference
Donnah Jones
1 reference
Cherie Perez
1 reference
Corazon Bucana
1 reference
Patricia Troncoso
1 reference
Sun-Jin Kim
1 reference
1 August 2004
1 reference
1 reference
22
1 reference
16
1 reference
3323-3329
1 reference
Identifiers
1 reference
1 reference